Tanja Dowe, Head of Debiopharm Innovation Fund, gives us her insights from the hard but exciting work of building a life science business and what it takes to make it in an ever rapidly changing industry.
This year’s Nobel discoveries in Medicine have provided us with answers about ourselves, for example our immune system and how to decipher genetic risks, but also about our origin and context. On October 3rd 2022, the Nobel Prize in Physiology or Medicine was awarded to Swedish geneticist Svante Pääbo, a…
…
Nordic Life Science asked Fredrik Dahl, co-founder at Colibri Ventures, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges Nordic life science companies facing when it comes to raising capital. Fredrik Dahl is one of four founders behind the Swedish investment company…
Immunicum announces corporate rebranding and name change to Mendus AB. The rebranding reflects an advancing pipeline in next generation cancer immunotherapies, upcoming manufacturing expansion, and long-term corporate aspirations, states the company. “The name Mendus captures our continued commitment to develop therapies that delay or reduce cases of cancer recurrence, while…
